Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703597 · ClinicalTrials.gov registry record · NA
Smoking Prevention Through Social Connections Among Adolescents - ASPIRE
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 393
- Enrollment target
NCT02703597: Completed NA study, sponsored by University of Florida.
NCT02703597 is a NA study that has completed, run by University of Florida. The registered enrollment target is 393 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02703597, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 393 participants
- Enrollment target
Study Summary
The central hypothesis of this study is that the addition of social influence strategies to a web-based program called ASPIRE will boost its success in lowering intention to use tobacco among adolescents and experiencing stronger positive social influence. The study will involve a nested group randomized controlled trial with adolescents from after-school programs and schools (e.g., the PK Yonge school) in Florida.
Primary Outcome
During the course of the study surveys reviewed. This outcome was measured using a binary form of the susceptibility to vaping scale, which aims at measuring intention to vape. Scores were 0 (non-susceptible) or 1 (susceptible). A score of 1 has a worse value than a score of 0.
Interventions
- BEHAVIORAL Surveys
- BEHAVIORAL ASPIRE
- BEHAVIORAL GSA-ASPIRE-Network
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 393 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-03-16 |
| Phase | NA |
What the finished NCT02703597 record still lists
NCT02703597 is an interventional study that assigns participants to a tested intervention. The registered 393 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 3 interventions - of which Surveys is the first listed.
NCT02703597 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02703597 about?
NCT02703597 is a clinical study titled "Smoking Prevention Through Social Connections Among Adolescents - ASPIRE". The central hypothesis of this study is that the addition of social influence strategies to a web-based program called ASPIRE will boost its success in lowering intention to use tobacco among adolescents and experiencing stronger positive social influence. The study will involve a nested group rando...
What is the current status of trial NCT02703597?
This trial is currently completed. It is a NA study. The enrollment target is 393 participants. The study started on 2021-06-01. Estimated completion is 2022-03-16.
What interventions are being tested in trial NCT02703597?
The interventions under investigation include: Surveys (BEHAVIORAL), ASPIRE (BEHAVIORAL), GSA-ASPIRE-Network (BEHAVIORAL).
Who is sponsoring clinical trial NCT02703597?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02703597's enrollment target sits among peer trials
393 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- NCT06613698 · 393 participants · Phase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI